Towards Healthcare Research & Consulting
Meningococcal Vaccines Market
Updated Date: 16 July 2026   |   Report Code: 6777
[email protected] +1 804-441-9344
Download Sample Order Now

Meningococcal Vaccines Market Size, Trends and Forecast 2026–2035

According to Rohan Patil, who specializes in conjugate meningococcal vaccines, serogroup B Meningococcal vaccines, and routine and travel vaccination services, individual mental health counselling, depression and anxiety counselling, and family and relationship counselling, with 5+ years of experience in market research and industry analysis, extensive research indicates strong growth opportunities in the meningococcal vaccines market. The global mental health counselling services market size was estimated at USD 4.09 billion in 2025 and is predicted to increase from USD 4.28 billion in 2026 to approximately USD 6.38 billion by 2035, expanding at a CAGR of 4.5% from 2026 to 2035. His analysis highlights the increasing adoption of conjugate meningococcal vaccines for broader serogroup protection, MenB vaccines among adolescents and high-risk populations, and next-generation vaccines with enhanced efficacy and longer-lasting immunity. The research also examines the competitive strategies of key industry participants, including GSK, Pfizer, Sanofi, Bio-Manguinhos/Fiocruz, AJ Vaccines, and Intravacc, shaping the future by improving vaccine formulation in recombinant and conjugates vaccines technologies, enhancing vaccine accessibility through expanded public health partnerships, supporting lifelong immunization strategies with durable and effective vaccines, and advancing next-generation multivalent meningococcal vaccine development in the global meningococcal vaccines services market.

Last Updated : 16 July 2026 Category: Pharmaceuticals Insight Code: 6777 Format: PDF / PPT / Excel

Content

Global XX Market

Chapter 1: Introduction

  • Market Definition & Taxonomy
  • Research Objectives
  • Market Scope & Assumptions
  • Study Timeline (Historical, Base Year, Forecast Period)
  • Key Stakeholders Covered

Chapter 2: Research Methodology

  • Research Framework Overview
  • Market Size Estimation Methodology
    • Bottom-Up Approach
    • Top-Down Approach
  • Forecasting Model
    • Dependent Variables
    • Independent Variables
    • Key Assumptions & Weightages
  • Primary Research Insights
  • Secondary Data Sources
  • Data Validation & Triangulation

Chapter 3: Executive Summary

  • Global & Regional Overview (Value, CAGR)
  • Epidemiology Snapshot
  • Segmental Overview
  • Competition Key Snippets
  • Strategic Takeaways

Chapter 4: Market Catalysts, Constraints & Growth Levers

  • Market Dynamics
  • Market Drivers/Catalysts
    • Driver 1
    • Driver 2
  • Market Restraints
    • Restraint 1
    • Restraint 2
  • Market Opportunities
    • Opportunity 1
    • Opportunity 2
  • Market Trends
    • Trend 1
    • Trend 2
  • Impact Assessment of Drivers, Restraints, Opportunities & Trends (High, Mid, & Low)

Chapter 5: Value Added Intelligence

  • Porter’s Five Forces Analysis
    • Bargaining Power of Suppliers: Low/Moderate/High
    • Bargaining Power of Buyers: Low/Moderate/High
    • Threat of New Entrants: Low/Moderate/High
    • Threat of Substitute: Low/Moderate/High
    • Competitive Rivalry: Low/Moderate/High
  • PESTEL Analysis
  • Ecosystem Analysis
  • Mapping of Key Players
  • Value Chain Analysis
  • Margin Analysis Across Value Chain
  • Macro & Micro Factors Impacting Market
  • Market Potential Evaluation, By Region
  • Epidemiology & Patient Pool Analysis
    • Disease Incidence & Prevalence
    • Target Patient Pool
      • Diagnosed Population
      • Service-Seeking Population
    • Patient Flow & Utilization Analysis
      • Patient Footfall
      • Admission Rates
      • Procedure Volume
    • Healthcare Infrastructure Analysis
      • Number of Facilities
        • Hospitals
        • Clinics
        • Diagnostic Centers
        • ASCs
      • Bed Capacity
        • Total Beds
        • ICU Beds
      • Facility Distribution
    • Operational Metrics Analysis
      • Bed Occupancy Rate (%)
      • Average Length of Stay (ALOS)
    • Service Pricing & Revenue Model
      • Pricing Analysis
        • Cost per Procedure
        • Cost per Consultation
        • Cost per Diagnostic Test
      • Revenue Streams
        • Inpatient Services
        • Outpatient Services
        • Ancillary Services
      • Workforce & Staffing Analysis
        • Healthcare Workforce
          • Physicians
          • Nurses
          • Technicians
        • Staff-to-Patient Ratios
        • Skill Gap Analysis
        • Labor Cost Structure
      • Scenario Analysis (Base / Optimistic / Pessimistic)
      • Risk Assessment & Sensitivity Analysis
      • Opportunity Analysis, By Region
      • Regulatory Analysis
      • Sustainability & ESG Insights
      • Business Models
      • Investment & Funding Landscape
      • Key Conferences and Events

Chapter 7: Segmental & Regional Analysis

  • Global Meningococcal Vaccines Market Analysis, By Type 
    • Market Size, Forecast & CAGR, By Type , 2022-2035
    • Key Rationale
    • Y-o-Y Analysis
  • Global Meningococcal Vaccines Market Analysis, By Brand
    • Market Size, Forecast & CAGR, By Type, 2022-2035
    • Key Rationale
    • Y-o-Y Analysis
  • Global Meningococcal Vaccines Market Analysis, By Serotye
    • Market Size, Forecast & CAGR, By Type , 2022-2035
    • Key Rationale
    • Y-o-Y Analysis
  • Global Meningococcal Vaccines Market Analysis, By Age Group
    • Market Size, Forecast & CAGR, By Type , 2022-2035
    • Key Rationale
    • Y-o-Y Analysis
  • Global Meningococcal Vaccines Market Analysis, By Sales Channel
    • Market Size, Forecast & CAGR, By Type, 2022-2035
    • Key Rationale
    • Y-o-Y Analysis
  • Global Meningococcal Vaccines Market Analysis, By Region
    • Market Size, Forecast & CAGR, By Type, 2022-2035
    • Key Rationale
    • Y-o-Y Analysis
  • North America Meningococcal Vaccines Market Analysis
  • North America Meningococcal Vaccines Market Analysis, By Type, 2022-2035
    • Key Rationale
    • Y-o-Y Analysis
  • North America Meningococcal Vaccines Market Analysis, By Brand, 2022-2035
    • Key Rationale
    • Y-o-Y Analysis
  • North America Meningococcal Vaccines Market Analysis, By Serotye, 2022-2035
    • Key Rationale
    • Y-o-Y Analysis
  • North America Meningococcal Vaccines Market Analysis, By Age Group, 2022-2035
    • Key Rationale
    • Y-o-Y Analysis
  • North America Meningococcal Vaccines Market Analysis, By Sales Channel, 2022-2035
    • Key Rationale
    • Y-o-Y Analysis
  • North America Meningococcal Vaccines Market Analysis, By Country, 2022-2035
    • Key Rationale
    • Y-o-Y Analysis
      • S. Meningococcal Vaccines Market Analysis
    • S. Meningococcal Vaccines Market Analysis, By Type, 2022-2035
    • Key Rationale
    • Y-o-Y Analysis
    • S. Meningococcal Vaccines Market Analysis, By Brand, 2022-2035
    • Key Rationale
    • Y-o-Y Analysis
    • S. Meningococcal Vaccines Market Analysis, By Serotye, 2022-2035
    • Key Rationale
    • Y-o-Y Analysis
    • S. Meningococcal Vaccines Market Analysis, By Age Group, 2022-2035
    • Key Rationale
    • Y-o-Y Analysis
    • S. Meningococcal Vaccines Market Analysis, By Sales Channel, 2022-2035
    • Key Rationale
    • Y-o-Y Analysis

Similar Analysis will be given for each country and each region

  • Canada
  • Mexico
  • Rest of North America

Europe

  • Western Europe
  • Germany
  • Italy
  • France
  • Spain
  • UK
  • Netherlands
  • Switzerland
  • Nordic Countries
  • Rest of Western Europe
  • Eastern Europe
  • Austria
  • Russia & Belarus
  • Poland
  • Türkiye
  • Rest of Eastern Europe

Asia Pacific

  • China
  • Taiwan
  • India
  • Japan
  • Vietnam
  • Australia and New Zealand
  • ASEAN Countries
  • South Korea
  • Rest of APAC

South America

  • Brazil
  • Argentina
  • Rest of South America

Middle East and Africa (MEA)

  • GCC Countries
  • South Africa
  • Egypt
  • Rest of MEA

Chapter 6: Competitive Insights

  • Competitive Analysis
    • Company Evaluation Matrix
      • Major Players
      • Mid-Sized Companies
      • Emerging Players/Start-Ups
    • Global Market Share Analysis, By Region, 2025 (%)
    • Key Player Positioning
    • Competitive Benchmarking
      • By Segment 1
      • By Segment 2
      • By Segment 3
    • Strategies of Key Players
    • Insight From the Horse’s Mouth

 

  • Company Profiles
    • Company 1
      • Company Name
      • Company Headquarters
      • Management Overview
        • Key C-Suite Executives
          • CEO
          • MD
          • Others
        • Employee Count
        • Business Strategy
          • Key Investments Made
          • Future Plans
          • R&D & Innovation Capabilities
          • Recent Developments
            • New Product Launch
            • Merger & Acquisitions
            • Partnerships & Collaborations
            • Market Expansion
            • Others
          • Service Portfolio
          • Facility Network
            • Number of Facilities
            • Bed Capacity
            • Facility Distribution
            • Expansion Pipeline
          • Key Financials (2022-2025)
            • Revenue By Segment
            • Revenue By Service
            • Revenue By Geography
            • Financial Matrix (Gross Profit Margins, Net Margins, etc.)
          • Key Clients
            • Client Company Name
            • Key Contact Person
            • Contact Details
          • Regulatory & Certification Expertise
          • SWOT Analysis

FAQ's

Answer : The meningococcal vaccines market in 2026 is valued at USD 4.28 billion and is projected to climb to USD 6.38 billion by 2035, with a CAGR of 4.5% over the forecast period.

Answer : North America is currently leading the meningococcal vaccines market by 56% due to the growth in disease awareness.

Answer : GOV.UK, Ministry of Health and Family Welfare, Government of India, National Institutes of Health, FDA, WHO, PIB, CDC.
Any Questions

Meet the Team

Rohan Patil is a seasoned market research professional with over 5+ years of focused experience in the healthcare sector, bringing deep domain expertise, strategic foresight, and analytical precision to every project he undertakes.

Learn more about Rohan Patil

Aditi Shivarkar is a seasoned professional with over 14 years of experience in healthcare market research. As a content reviewer, Aditi ensures the quality and accuracy of all market insights and data presented by the research team.

Learn more about Aditi Shivarkar